Our Partners
[lsp_slider slider=our_partners]
Trending Now
Features
More
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
T.A.C jubilance gets reverberated with Debutant of the year from India...
New Delhi, June 13, 2022: India's fastest-growing D2C brand in the natural healthcare industry, The Ayurveda Company aka T.A.C has clinched another glory by...
How to fight piles during lockdown
By Dr. Mahesh Chikkachannappa, Sr. Consultant - General, Laparoscopic & Bariatric Surgery, Aster CMI Hospital
Piles, which is a serious health problem, and has many...
Medical Tourism
More
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
POPULAR NEWS
More
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
Here’s a Hygiene Wash for Both Men and Women
New Delhi, April 16, 2019: Namyaa Skincare has introduced its new Intimate Hygiene Wash for both men and women. The intimate hygiene is something that must be...
Biotechnology
HCG Cancer Hospital completes Comprehensive Genomic Profiling (CGP) of 1000+ Cancer Patients
Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...
IT & Software Support
Wipro GE Healthcare keen to make diagnostics affordable to all
Wipro GE Healthcare is keen to invest in technologies that are affordable to all.
Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.
INDIA MANUFACTURE
“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.
Appointments
Novartis India Limited reconstitutes Board; appoints Sanjay Murdeshwar as Vice Chairman & Managing Director
Mumbai, June 15, 2019: At a meeting held in Mumbai today, the Board of Directors of Novartis India Limited announced the appointment of Sanjay...
Awards
Wockhardt showcases KailashSatyarthi documentary; Felicitates him with Lifetime Achievement Award
New Delhi, July 12, 2019: The Wockhardt Group hosted Mr. KailashSatyarthi and his wife in Mumbai on Sunday evening and held a screening of his...
Financial Results
Max Healthcare Q1 FY21 Performance
Max Healthcare plays a significant role in combating Covid 19 in Delhi and Mumbai....
Hester Biosciences Ltd Consolidated Net Profit in Q3 FY25 up 184% Y-o-Y to Rs. 11.41 crore; EBITDA up 12% to Rs. 13.85 crore
· In 9M FY25 Net Profit up 85% Y-o-Y to Rs. 27.29 crore
· In 9M FY25 EBITDA...
APL Apollo Quarterly Results.
New Delhi, August 17, 2019: APL Apollo Tubes Limited (APL Apollo), India’s leading branded steel...
Clinical Trails
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...
Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.
Bulk Drug
Health Care
Alternative Medicine
Eye Care
All you need to know about Eye Fillers
New Delhi, September 15, 2023: Recently, social media influencer Uorfi Javed opted for eye fillers to address dark circles and hollowness under her eyes....
Unlocking Vision Wellness: Allergan’s Media Conclave on World Sight Day Spotlights Eyecare’s Crucial Role...
New Delhi, October 12, 2023 : This World Sight Day, Allergan, an AbbVie company, came together with renowned experts in the field of ophthalmology...
Importance of eye health during this lockdown and 5 ways to keep our eyes...
By Hemanth Manay, CEO & Chief Consultant Optometrist, S.R. Gopal Rao Opticians & Optometrists
The current situation does not allow for us to move out...
Product News
Approvals
Lupin Receives Approval for Meloxicam Capsules
Mumbai, June 02, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg and 10 mg, from...
Spotlight
SCHOTT Glass wins top awards at vendor meet organized by Borosil Klasspack
02:48
Indian Pharmaceutical Market forecast 2016-2026
00:16
Indian Pharmaceutical Industry has emerged as 3rd largest producer in the world Pharmacy College
07:27
Pharmaceuticals Industry in India 2015 - 2020
02:36
India Pharma Awards 2015
25:11
Aurobindo Pharma Corporate Film
13:14
Pharmaceutical Industry in India
03:14
Made In India-Pharmaceutical Industry-2015
09:19
Dr. Sunil Chandy Speaking on the topic Scaling up tertiary care in hinterland India
28:45
Phases of Pharmaceutical Industry
13:49
Latest News
DKMS India and IIT Hyderabad Join Hands to Create Awareness About Blood Stem Cell...
Dkms Foundation India held a blood stem cell donation drive at IIT Hyderabad 's techno-cultural festival Elan & nVision 2025
Hyderabad, March 05, 2025: DKMS Foundation...
Save a life by registering as a blood stem cell donor
Aster CMI launches initiative for blood stem cell donor registration and urges all to come forward and volunteer for a mission
Bangalore, June 29, 2019:...
Travel Ban on Immune Cells Could Prevent Sepsis
Lactate, thought to be a byproduct of cell respiration, plays a central role in the potentially lethal immune reaction
New Delhi, October 14, 2020: The World...
Is A Man As Young As His Spinal Column??
Dr Palak Dengla, Chief Physiotherapist, Aster RV Hospital
Joseph Pilates said- "If your spine is stiff at 30, you are old, if it is flexible...
Dental Care
Tips to maintain oral health!
By Dr.MS Prasad, Dental Surgeon, Columbia Asia Referral Hospital Yeshwanthpur
It has been said that a person’s real happiness begins from the plate and is...
Hospital Management
Common Symptoms of Gallbladder Cancer: Recognizing the Signs
By Dr Satya Srinivas A, Consultant - Medical Oncologist, HCG Cancer Centre, Vijaywada
One of the most rare but serious forms of cancer is Gallbladder cancer...
HCG Cancer Hospital completes Comprehensive Genomic Profiling (CGP) of 1000+ Cancer Patients
Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...
Drug Discovery & Development
Suppliers
Technology
Companies
Your everyday habits could be mounting trouble for your heart
By Dr. Naveen Chandra-Consultant - Interventional Cardiology, Columbia Asia Hospital Whitefield
From a time when cardiac arrest was a rare phenomenon usually occurring due to...
